#regeneron hereditary deafness otof mutation

FDA Approves Otarmeni: The Gene Therapy That Gives Hearing to Children Born Deaf

Regeneron's Otarmeni became the first FDA-approved gene therapy for hereditary hearing loss caused by OTOF gene mutations in April 2026, restoring hearing in children who were profoundly deaf from bir